Levosimendan

Levosimendan

CAT N°: 16128
Price:

From 85.00 72.25

Levosimendan is a calcium sensitizer that can cause increased cardiac contractility by binding troponin C (EC50 = 9 nM), promotes vasodilation by activating ATP-sensitive potassium channels on vascular smooth muscle cells (EC50 = 0.28 µM), and performs a cardioprotective function by prompting the opening of mitochondrial potassium channels in cardiomyocytes.{26307,26308} It also has been reported to inhibit phosphodiesterases 3 and 4 in left ventricular cardiac tissue with IC50 values of 2.5 nM and 25 µM, respectively.{26309}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 2-[2-[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]hydrazinylidene]-propanedinitrile
  • Correlated keywords
    • 131741-08-7 inodilator hearts failures ionotropic vasodilators calcium sensitizers Ca2+ acutely decompensated acute myocardial infarction cardiac contractions troponin C vasodilation ATP-sensitive ATP sensitive potassium channels K+ vascular smooth muscles cardioprotective mitochondrial cardiomyocytes inhibitors inhibits inhibitions PDE3 PDE4 phosphodiesterases 3 4 three four contractility cardiology ions pumps (-)-OR 1259 (-)-OR1259 (-)-OR-1259 OR OR1259 OR-1259
  • Product Overview:
    Levosimendan is a calcium sensitizer that can cause increased cardiac contractility by binding troponin C (EC50 = 9 nM), promotes vasodilation by activating ATP-sensitive potassium channels on vascular smooth muscle cells (EC50 = 0.28 µM), and performs a cardioprotective function by prompting the opening of mitochondrial potassium channels in cardiomyocytes.{26307,26308} It also has been reported to inhibit phosphodiesterases 3 and 4 in left ventricular cardiac tissue with IC50 values of 2.5 nM and 25 µM, respectively.{26309}

We also advise you